• Molecular NameEmepronium
  • SynonymNA
  • Weight282.451
  • Drugbank_IDN/A
  • ACS_NO27892-33-7
  • Show 3D model
  • LogP (experiment)0.5
  • LogP (predicted, AB/LogP v2.0)0.37
  • pkaN/A
  • LogD (pH=7, predicted)0.37
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.17
  • LogSw (predicted, AB/LogsW2.0)10.61
  • Sw (mg/ml) (predicted, ACD/Labs)191.42
  • No.of HBond Donors0
  • No.of HBond Acceptors1
  • No.of Rotatable Bonds6
  • TPSA0.0
  • StatusN/A
  • AdministrationN/A
  • PharmacologyAn anticholinergic drug used in urology as an antispasmodic.
  • Absorption_valueN/A
  • Absorption (description)Poorly absorbed after oral administration
  • Caco_2N/A
  • Bioavailability1.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifePlasma half-life, about 7 to 11 h.
  • Excretionless than 5% of a dose is excreted in the urine in 24 h, partly as metabolites. After intramuscular administration, about 30% of a dose is excreted in the urine in 3 days and 45% is eliminated in the faeces in the same period.
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A